Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Visual Acuity | 8 | 2026 | 77 | 2.780 |
Why?
|
| Tomography, Optical Coherence | 8 | 2026 | 47 | 2.640 |
Why?
|
| Retina | 5 | 2019 | 84 | 2.330 |
Why?
|
| Vitrectomy | 3 | 2024 | 10 | 1.270 |
Why?
|
| Fluorescein Angiography | 6 | 2026 | 18 | 1.250 |
Why?
|
| Retinal Vessels | 2 | 2019 | 26 | 1.220 |
Why?
|
| Anemia, Sickle Cell | 3 | 2026 | 47 | 1.040 |
Why?
|
| Alzheimer Disease | 2 | 2018 | 302 | 0.880 |
Why?
|
| Basement Membrane | 1 | 2024 | 8 | 0.860 |
Why?
|
| Retinal Perforations | 1 | 2024 | 4 | 0.860 |
Why?
|
| Retinal Diseases | 2 | 2026 | 26 | 0.830 |
Why?
|
| Meningocele | 1 | 2023 | 1 | 0.820 |
Why?
|
| Surgical Flaps | 1 | 2024 | 77 | 0.820 |
Why?
|
| Optic Nerve Diseases | 1 | 2023 | 19 | 0.800 |
Why?
|
| Optic Nerve | 2 | 2023 | 16 | 0.770 |
Why?
|
| Macular Edema | 2 | 2023 | 17 | 0.740 |
Why?
|
| Retinal Detachment | 4 | 2024 | 10 | 0.720 |
Why?
|
| Vision Disorders | 2 | 2018 | 26 | 0.710 |
Why?
|
| Macular Degeneration | 2 | 2018 | 27 | 0.640 |
Why?
|
| Choroid | 1 | 2019 | 4 | 0.630 |
Why?
|
| Choroidal Neovascularization | 1 | 2019 | 9 | 0.620 |
Why?
|
| Ophthalmology | 2 | 2024 | 7 | 0.610 |
Why?
|
| Retinal Necrosis Syndrome, Acute | 1 | 2018 | 1 | 0.580 |
Why?
|
| Eye Infections, Viral | 1 | 2018 | 3 | 0.580 |
Why?
|
| Herpesvirus 1, Human | 1 | 2018 | 8 | 0.580 |
Why?
|
| Herpes Simplex | 1 | 2018 | 13 | 0.580 |
Why?
|
| Macula Lutea | 1 | 2018 | 9 | 0.560 |
Why?
|
| Peritoneal Dialysis | 1 | 2017 | 25 | 0.530 |
Why?
|
| Conjunctiva | 1 | 2017 | 5 | 0.520 |
Why?
|
| Eye Neoplasms | 1 | 2017 | 3 | 0.520 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2017 | 9 | 0.520 |
Why?
|
| Cornea | 1 | 2017 | 18 | 0.510 |
Why?
|
| Colitis, Ulcerative | 1 | 2017 | 24 | 0.510 |
Why?
|
| Diabetic Retinopathy | 1 | 2017 | 73 | 0.510 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2026 | 39 | 0.500 |
Why?
|
| Humans | 19 | 2026 | 32969 | 0.490 |
Why?
|
| Epithelial Cells | 1 | 2017 | 129 | 0.490 |
Why?
|
| Child, Preschool | 4 | 2019 | 1282 | 0.450 |
Why?
|
| Retrospective Studies | 7 | 2026 | 3708 | 0.440 |
Why?
|
| Female | 12 | 2026 | 20375 | 0.430 |
Why?
|
| Follow-Up Studies | 6 | 2026 | 2287 | 0.420 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2013 | 22 | 0.400 |
Why?
|
| Male | 11 | 2026 | 19754 | 0.400 |
Why?
|
| Delivery of Health Care | 2 | 2024 | 166 | 0.400 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 543 | 0.390 |
Why?
|
| Guideline Adherence | 1 | 2013 | 120 | 0.380 |
Why?
|
| Continuity of Patient Care | 1 | 2013 | 73 | 0.380 |
Why?
|
| Child | 4 | 2019 | 2478 | 0.370 |
Why?
|
| Adolescent | 5 | 2026 | 3643 | 0.370 |
Why?
|
| Brain | 1 | 2018 | 949 | 0.350 |
Why?
|
| Infant | 3 | 2019 | 1083 | 0.340 |
Why?
|
| Internship and Residency | 1 | 2013 | 325 | 0.300 |
Why?
|
| Scleral Buckling | 2 | 2024 | 4 | 0.270 |
Why?
|
| Treatment Outcome | 4 | 2026 | 3460 | 0.270 |
Why?
|
| Middle Aged | 6 | 2026 | 12203 | 0.250 |
Why?
|
| Retinal Neovascularization | 1 | 2026 | 6 | 0.240 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2026 | 22 | 0.240 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2026 | 106 | 0.230 |
Why?
|
| Body Fluids | 1 | 2025 | 8 | 0.230 |
Why?
|
| Epiretinal Membrane | 1 | 2024 | 2 | 0.220 |
Why?
|
| Aged | 4 | 2024 | 10637 | 0.210 |
Why?
|
| Uncompensated Care | 1 | 2024 | 4 | 0.210 |
Why?
|
| Stem Cell Transplantation | 1 | 2025 | 212 | 0.200 |
Why?
|
| Stem Cells | 1 | 2025 | 314 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2026 | 118 | 0.180 |
Why?
|
| Fundus Oculi | 1 | 2019 | 13 | 0.160 |
Why?
|
| Capillaries | 1 | 2019 | 23 | 0.160 |
Why?
|
| Adult | 4 | 2026 | 9586 | 0.150 |
Why?
|
| Hemoglobin, Sickle | 1 | 2019 | 8 | 0.150 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 1582 | 0.150 |
Why?
|
| Eye Enucleation | 1 | 2019 | 4 | 0.150 |
Why?
|
| Paraffin Embedding | 1 | 2019 | 10 | 0.150 |
Why?
|
| Organ Size | 1 | 2019 | 220 | 0.150 |
Why?
|
| Foscarnet | 1 | 2018 | 1 | 0.150 |
Why?
|
| Cryosurgery | 1 | 2019 | 23 | 0.150 |
Why?
|
| Laser Therapy | 1 | 2019 | 56 | 0.140 |
Why?
|
| Fibrosis | 1 | 2019 | 125 | 0.140 |
Why?
|
| Atrophy | 1 | 2018 | 46 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 199 | 0.140 |
Why?
|
| Antiviral Agents | 1 | 2018 | 108 | 0.140 |
Why?
|
| Forecasting | 1 | 2018 | 143 | 0.130 |
Why?
|
| Methylprednisolone Hemisuccinate | 1 | 2017 | 2 | 0.130 |
Why?
|
| Mesalamine | 1 | 2017 | 2 | 0.130 |
Why?
|
| Laser Coagulation | 1 | 2017 | 13 | 0.130 |
Why?
|
| Prednisone | 1 | 2017 | 63 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2017 | 99 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 69 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2017 | 151 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 527 | 0.110 |
Why?
|
| Disease Progression | 1 | 2017 | 594 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2019 | 2338 | 0.100 |
Why?
|
| Academies and Institutes | 1 | 2013 | 5 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2017 | 1852 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2013 | 163 | 0.090 |
Why?
|
| Oxidants | 1 | 2012 | 15 | 0.090 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2012 | 25 | 0.090 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 265 | 0.090 |
Why?
|
| United States | 2 | 2024 | 4133 | 0.080 |
Why?
|
| Young Adult | 2 | 2026 | 2738 | 0.070 |
Why?
|
| Charities | 1 | 2024 | 1 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 254 | 0.040 |
Why?
|
| Animals | 2 | 2025 | 7599 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2023 | 828 | 0.040 |
Why?
|
| Risk Factors | 1 | 2023 | 4001 | 0.030 |
Why?
|